Obesity drug from Zealand shows potential in early trial

An experimental weight loss shot developed by Denmark-based Zealand Pharma helped people with obesity lose as much as 9% of their body weight over four months, results the company said support further research on a medicine it hopes could compete with drugs from Novo Nordisk and Eli Lilly.